Md Yousof Ali | Diabetes | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Md Yousof Ali
University of Calgary, Canada

              Md Yousof Ali
Affiliation University of Calgary
Country Canada
Scopus ID 55984478600
Documents 56
Citations 2,070
h-index 28
Subject Area Diabetes
Event Global Diseases Research Awards
ORCID 0000-0003-1488-5711

The Innovative Research Award profile recognizes the research record of Md Yousof Ali, affiliated with the University of Calgary in Canada. The supplied bibliometric information identifies a research portfolio comprising 56 documents, 2,070 citations, and an h-index of 28, with diabetes designated as the principal subject area. [1]

Abstract

Md Yousof Ali is a researcher affiliated with the University of Calgary, Canada, whose supplied scholarly profile is associated with diabetes research. The reported Scopus record contains 56 documents, 2,070 citations, and an h-index of 28. These indicators provide a quantitative overview of publication activity and citation visibility within indexed scholarly literature. The profile is presented in connection with the Global Diseases Research Awards and the proposed Innovative Research Award. The recognition framework emphasizes documented research activity, disciplinary relevance, scholarly contribution, and measurable bibliometric evidence while avoiding unsupported claims regarding individual discoveries or clinical outcomes. [1]

Keywords

Md Yousof Ali; University of Calgary; diabetes research; diabetes; biomedical research; clinical research; scholarly publications; Scopus; citation impact; h-index; research recognition; Global Diseases Research Awards; Innovative Research Award; academic research; disease research.

Introduction

Academic recognition in disease research commonly considers evidence such as institutional affiliation, peer-reviewed scholarly output, citation activity, disciplinary relevance, and sustained research engagement. In this context, the supplied profile of Md Yousof Ali identifies the University of Calgary as the institutional affiliation and diabetes as the principal subject area. [1]

Research Profile

The research profile supplied for Md Yousof Ali records 56 documents and 2,070 citations, alongside an h-index of 28. These figures describe the indexed publication and citation record provided for the researcher. Scopus author identification enables bibliometric records to be associated with an individual author profile and supports structured assessment of scholarly productivity and citation activity. [1]

Research Contributions

Within the supplied classification, diabetes represents the principal subject area associated with the research profile. The documented publication volume provides evidence of continuing scholarly activity, while the citation count indicates that the indexed publications have received substantial scholarly referencing. Detailed claims concerning individual methodologies, discoveries, collaborations, or clinical applications require verification from the underlying publications. [2]

Publications

The supplied Scopus information indicates a total of 56 indexed documents associated with the researcher identifier 55984478600. The publication count should be interpreted as a bibliometric measure rather than a qualitative assessment of individual studies. Article-level titles, journals, publication years, authorship positions, and DOI identifiers should be verified against authoritative publisher or indexing records before being used for detailed bibliographic evaluation. [1]

Research Impact

The reported 2,070 citations and h-index of 28 provide quantitative indicators of scholarly visibility for the supplied profile. Citation-based measures can assist comparative evaluation but do not independently establish research quality, societal benefit, originality, or clinical significance. Consequently, these indicators are best considered alongside publication quality, methodological rigor, relevance, and independently verifiable research contributions. [3]

Award Suitability

The supplied research record presents several measurable characteristics relevant to an academic recognition profile: an established institutional affiliation, documented publication activity, citation visibility, and a defined research subject area in diabetes. These characteristics may support consideration for an Innovative Research Award within the Global Diseases Research Awards, subject to the event’s eligibility requirements and independent evaluation of submitted evidence. [4]

Conclusion

Md Yousof Ali’s supplied academic profile reflects research activity associated with the University of Calgary and diabetes, supported by reported Scopus metrics of 56 documents, 2,070 citations, and an h-index of 28. These indicators establish a useful bibliometric foundation for an academic recognition profile, while comprehensive award assessment should incorporate verified scholarly evidence and contribution-specific evaluation. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Md Yousof Ali, Author ID 55984478600. Scopus.
    https://www.scopus.com/pages/authors/55984478600
  2. ORCID. (n.d.). ORCID record: Md Yousof Ali. ORCID.
    https://orcid.org/0000-0003-1488-5711
  3. Global Diseases Research Awards. (n.d.). Official award website.
    https://globaldiseases.org/
  4. Choi, J. S., Nurul Islam, M., Yousof Ali, M., Kim, E. J., Kim, Y. M., & Jung, H. A. (2014). Effects of C-glycosylation on anti-diabetic, anti-Alzheimer’s disease and anti-inflammatory potential of apigenin. Food and Chemical Toxicology, 64, 27–33. https://doi.org/10.1016/j.fct.2013.11.020
  5. Choi, J. S., Islam, M. N., Ali, M. Y., Kim, Y. M., Park, H. J., Sohn, H. S., & Jung, H. A. (2014). The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer’s disease, anti-diabetic, and anti-inflammatory activities. Archives of Pharmacal Research, 37, 1354–1363.
    https://doi.org/10.1007/s12272-014-0351-3

Roberto Berni Canani | Non-Communicable Diseases | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Roberto Berni Canani
Università degli Studi di Napoli Federico II, Italy

                 Roberto Berni Canani
Affiliation Università degli Studi di Napoli Federico II
Country Italy
Scopus ID 57008139600
Documents 330
Citations 26,391
h-index 72
Subject Area Non-Communicable Diseases
Event Global Diseases Research Awards
ORCID 0000-0002-5169-9574

Roberto Berni Canani is a researcher affiliated with the Università degli Studi di Napoli Federico II, Italy, whose academic profile encompasses pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research integrates clinical and translational perspectives, contributing to scientific understanding of gastrointestinal health, nutrition-related mechanisms, immune responses, and disease prevention within biomedical research. [1]

Abstract

Roberto Berni Canani is an Italian researcher affiliated with the Università degli Studi di Napoli Federico II whose academic activities encompass pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research profile reflects multidisciplinary investigation connecting clinical medicine with nutritional, immunological, gastrointestinal, and translational research. The supplied Scopus information records 330 documents, 26,391 citations, and an h-index of 72. His scientific work addresses relationships between nutrition, intestinal biology, immune responses, allergic conditions, and disease mechanisms, contributing to evidence-based understanding of health and disease. These research areas provide a relevant academic foundation for consideration for the Research Excellence Award within the Global Diseases Research Awards. [2]

Keywords

Roberto Berni Canani, Research Excellence Award, pediatric medicine, gastroenterology, nutrition, allergy, microbiome, food-induced diseases, gastrointestinal health, immunology, translational research, non-communicable diseases, biomedical research, Università degli Studi di Napoli Federico II, Italy. [2]

Introduction

Research into nutrition, gastrointestinal health, allergy, and immune-mediated disease has become increasingly interdisciplinary, combining clinical investigation with biological and nutritional sciences. Roberto Berni Canani’s academic profile is positioned within these interconnected fields, with research addressing pediatric health and disease mechanisms. His institutional affiliation provides an academic setting for multidisciplinary scientific investigation and collaboration.[1]

Research Profile

Roberto Berni Canani is affiliated with the Università degli Studi di Napoli Federico II and has an academic research profile indexed through Scopus. The supplied record identifies 330 documents, 26,391 citations, and an h-index of 72. His research interests encompass nutrition, pediatric gastroenterology, allergy, microbiome science, and food-related disease research.[1]

Research Contributions

Berni Canani’s research contributions include investigation of relationships among nutrition, gastrointestinal function, immune responses, and allergic disease. These areas are relevant to understanding how dietary exposures and biological processes interact in childhood health. His work illustrates an interdisciplinary research approach combining clinical questions with nutritional, immunological, and translational perspectives.[2]

Publications

The researcher’s publication record covers scientific topics associated with pediatric allergy, nutrition, gastrointestinal disorders, and related biomedical disciplines. His scholarly output contributes to peer-reviewed scientific communication and supports continuing investigation of mechanisms underlying disease and health. Publication activity also provides a basis for evaluating research development, collaboration, and dissemination across relevant academic communities.[1]

Research Impact

The supplied Scopus profile records 330 documents, 26,391 citations, and an h-index of 72, providing quantitative indicators of the visibility of the researcher’s indexed scholarly output. Such bibliometric measures offer useful context when assessing academic activity, although research impact is more comprehensively considered alongside publication quality, originality, collaboration, and substantive scientific contribution.[3]

Award Suitability

The documented academic profile is relevant to a Research Excellence Award because it demonstrates sustained scholarly activity across several interconnected biomedical disciplines. His research focus on nutrition, allergy, gastrointestinal health, microbiome-related science, and pediatric disease provides a multidisciplinary foundation for evaluation. The available publication and citation indicators further support consideration within an academic recognition framework.[4]

Conclusion

Roberto Berni Canani’s academic profile reflects sustained research activity in pediatric medicine, nutrition, gastroenterology, allergy, and related biomedical fields. His documented scholarly indicators and multidisciplinary research interests provide a substantial basis for academic evaluation. His work demonstrates the relevance of integrating clinical, nutritional, immunological, and translational perspectives in contemporary health research.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Roberto Berni Canani, Author ID 57008139600. Scopus.
    https://www.scopus.com/pages/authors/57008139600
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award Recognition. Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  4. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Berni Canani, R., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11, 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  5. Canani, R. B., Di Costanzo, M., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12), 1519–1528.
    https://doi.org/10.3748/wjg.v17.i12.1519